U-Blot® Research Grade GivastomigCat. No. WA2920$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade GivastomigCat. No. WA2920
U-Blot® Research Grade girocovateinCat. No. WA2919
U-Blot® Research Grade GirentuximabCat. No. WA2918
U-Blot® Research Grade girancitugCat. No. WA2917
U-Blot® Research Grade GinisortamabCat. No. WA2916
U-Blot® Research Grade gimvekibartCat. No. WA2915
U-Blot® Research Grade GimsilumabCat. No. WA2914
U-Blot® Research Grade GimistotugCat. No. WA2913
U-Blot® Research Grade GilvetmabCat. No. WA2912
U-Blot® Research Grade GiloralimabCat. No. WA2911
U-Blot® Research Grade GevokizumabCat. No. WA2910
U-Blot® Research Grade GeptanolimabCat. No. WA2909